Tradestie Institutional Equity Comparison Engine

ELVN vs TLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TLX Overall Edge

TLX Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Telix Pharmaceuticals Limited American Depositary Shares (TLX) driven by superior Valuation, Growth & Margin while ELVN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ELVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TLX at N/M Forward P/E and 6.2% operating margin (+22.3% YoY). In options structure, ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against TLX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TLX
ELVN N/M vs TLX N/M Fwd P/E
Growth & Margin Winner TLX
Op Margin 0.0% vs 6.2% ยท YoY +0.0% vs +22.3%
Momentum & Technical Winner ELVN
1Y +134.5% vs -5.5% ยท 52W Pos 69% vs 40%
Options & Structure Winner ELVN
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
ELVN NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap $3.6B
1M Return +27.38%
1Y Return +134.53%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 15.0 Fund 42.0 Flow 68.0 Mom 60.0
TLX NASDAQ
Telix Pharmaceuticals Limited American Depositary Shares
Pharmaceutical Preparations
$8.98
-2.65% 1D
Market Cap $3.2B
1M Return -15.95%
1Y Return -5.52%
Forward P/E N/M
Unified AI Score
55.2 / 100 HOLD
Tech 74.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ELVN +134.53% TLX -5.52% Spread: +140.05 pp (ELVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ELVN TTM Op. Margin: 0.0% TLX TTM Op. Margin: 6.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELVN vs TLX. Trailing 12-month operating profitability (ELVN 0.0% vs TLX 6.2%) and valuation multiples (ELVN N/M vs TLX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ELVN (3) vs TLX (6)
Institutional Metric ELVN TLX Criterion Row Winner
Market Capitalization Scale $3.6B $3.2B Larger Scale ELVN
Trailing P/E Ratio Valuation N/M 93.6x Lower Multiple TLX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +22.3% Higher Growth TLX
Operating Margin (TTM) Profitability 0.0% 6.2% Higher Margin TLX
Net Profit Margin Profitability 0.0% 3.8% Higher Margin TLX
Return on Equity (ROE) Capital Efficiency -16.8% 7.4% Higher ROE TLX
52-Week Range Position Momentum 69% ($15โ€“$62) 40% ($6โ€“$13) Stronger Trend ELVN
Beta / 30D Volatility Risk Regime 0.96ฮฒ ยท 60% Vol 0.84ฮฒ ยท 62% Vol Lower Realized Risk ELVN
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 55.2 / 100 (HOLD) Higher Composite TLX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ELVN vs TLX Buy Guide
ELVN CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ELVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ELVN nor TLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.